{"id":1685,"date":"2026-04-19T09:05:13","date_gmt":"2026-04-19T09:05:13","guid":{"rendered":"https:\/\/sovea.rs\/?page_id=1685"},"modified":"2026-04-23T18:17:52","modified_gmt":"2026-04-23T18:17:52","slug":"celluma","status":"publish","type":"page","link":"https:\/\/sovea.rs\/?page_id=1685","title":{"rendered":"CELLUMA"},"content":{"rendered":"\n
\n
\n

CELLUMA<\/h1>\n<\/div><\/div>\n<\/div>\n\n\n\n
<\/div><\/div>
\n
\n
\n
\n
\n

LUM\u00c9<\/p>\n\n\n\n

Svetlosna terapija \u00b7 LED<\/p>\n<\/div>\n\n\n\n

\n

INDIKACIJE<\/p>\n\n\n

Materijali<\/span><\/span><\/span><\/div><\/div>\n<\/div><\/div>\n\n\n\n
\n
\n

cena<\/p>\n\n\n\n

\u20ac25 30 min \/ \u20ac40 60 min<\/p>\n<\/div>\n\n\n\n

\n

LINK<\/p>\n\n\n\n

Pitanja<\/span><\/span><\/svg><\/span><\/a><\/div>\n<\/div>\n<\/div><\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n
\n

Svetlost kao medicina: \u0161ta Celluma zaista radi ispod povr\u0161ine ko\u017ee<\/p>\n<\/div><\/div>\n<\/div><\/div><\/div>\n\n\n\n

\n
<\/div><\/div>
<\/div><\/div><\/div>\n<\/div>\n\n\n\n
\n
\n
\n
\n

ISTORIJA<\/h3>\n<\/div><\/div>\n<\/div>\n\n\n\n
\n
\n

SVETLOSNA TERAPIJA<\/h3>\n<\/div><\/div>\n\n\n\n
\n

Pri\u010da o fotobiomodulaciji po\u010dinje 1967. godine, u laboratoriji ma\u0111arskog lekara Endrea Mestera na Univerzitetu Semmelweis, kada je posmatrao kako laserska svetlost niske intenzivnosti ubrzava rast dlake kod mi\u0161eva i podsti\u010de zarastanje rana koje ina\u010de ne bi zarastale. Nije planirao otkri\u0107e \u2014 planirao je da uni\u0161ti tumor. Umesto toga, dobio je ne\u0161to neuporedivo vrednije: dokaz da svetlost, kada se upotrebi u preciznoj dozi i na ta\u010dnoj talasnoj du\u017eini, direktno razgovara sa \u017eivim tkivom.<\/p>\n\n\n\n

Decenijama je svetlost bila samo metafora za ozdravljenje. Danas je to klini\u010dki izmerena, FDA-odobrena terapija koja menja na\u010din na koji \u0107elije proizvode energiju. Uveli smo je 2019. \u2014 i razlog le\u017ei duboko u mitohondrijama.<\/p>\n\n\n\n

Vi\u0161e od pedeset godina i nekoliko hiljada recenziranih studija kasnije, ta ista nauka stoji iza Cellume \u2014 ure\u0111aja koji koristimo u ordinaciji od 2019. Odluka nije bila impulsivna. Bila je zasnovana na tome ko je Cellumu odobrio, kako funkcioni\u0161e, i za\u0161to sama fizika njene konstrukcije \u010dini razliku.Kada smo 2019. odlu\u010dili da uvedemo fotobiomodulaciju u ordinaciju, kriterijum nije bio estetika ure\u0111aja niti marketin\u0161ka naracija. Pitanje je bilo jedno: koji ure\u0111aj ima dokazanu klini\u010dku efikasnost, regulatornu verifikaciju na vi\u0161e tr\u017ei\u0161ta, i fizi\u010dku konstrukciju koja zaista isporu\u010duje dozu svetlosti kakva se koristi u studijama?<\/p>\n\n\n\n

Celluma je tada \u2014 a i danas \u2014 ure\u0111aj sa najvi\u0161e medicinskih dozvola i regulatornih odobrenja od bilo kog LED ure\u0111aja na svetskom tr\u017ei\u0161tu. Koriste ga dermatolozi, hirurzi, fizijatri i klinike za upravljanje bolom u vi\u0161e od 100 zemalja. \u0106elija mo\u017ee da apsorbuje svetlost samo ako fotoni imaju talasnu du\u017einu koja odgovara apsorpcionom spektru njenih hromofora \u2014 i to je razlika izme\u0111u medicinskog ure\u0111aja i dekorativnog osvetljenja.<\/p>\n<\/div><\/div>\n<\/div>\n<\/div><\/div>\n<\/div>\n\n\n\n

\n
\n
\n
\n

\u0160ta je Celluma?<\/h3>\n<\/div><\/div>\n<\/div>\n\n\n\n
\n
\n

celluma<\/h3>\n<\/div><\/div>\n\n\n\n
\n

Celluma je profesionalni LED terapijski ure\u0111aj koji emituje svetlost tri precizne talasne du\u017eine: plavu od 465 nm, crvenu od 640 nm, i blisku infracrenu od 880 nm.\u00a0FDA cleared\u00a0Registrovan je kao medicinski ure\u0111aj Klase II od strane ameri\u010dke FDA, kao i CE (Evropa), TGA (Australija) i Health Canada \u2014 \u0161to ga svrstava u isti regulatorni okvir kao dijagnosti\u010dku opremu i hirur\u0161ke instrumente, a ne kao kozmeti\u010dke gad\u017eete.<\/p>\n\n\n\n

Ono po \u010demu je strukturalno jedinstven jeste patentirani fleksibilni panel koji se oblikuje prema konturama tela \u2014 jer ljudsko telo nije ravna povr\u0161ina. Distanca izme\u0111u izvora svetlosti i ko\u017ee nije detalj; to je fizi\u010dki zakon. Prema zakonu inverznog kvadrata, svako pove\u0107anje razmaka eksponencijalno smanjuje intenzitet svetlosti koja dopire do tkiva. Celluma je konstruisana da bude \u0161to bli\u017ee ko\u017ei \u2014 dosledno, ravnomerno, na svakom delu tretiranog podru\u010dja.<\/p>\n\n\n\n

“Svetlosna energija nema efekta ukoliko ne dostigne ciljno tkivo u pravoj dozi. Distanca, talasna du\u017eina i vreme trajanja tretmana nisu preferencije \u2014 to su promenljive koje odre\u0111uju ishod.”<\/p>\n<\/div><\/div>\n<\/div>\n<\/div><\/div>\n<\/div>\n\n\n\n

\n
\n
\n
\n

Nauka: \u0161ta se de\u0161ava u \u0107eliji<\/h3>\n<\/div><\/div>\n<\/div>\n\n\n\n
\n
\n

\u0106ELIJA<\/h3>\n<\/div><\/div>\n\n\n\n
\n

Fotobiomodulacija funkcioni\u0161e po principu koji je u biologiji poznat ve\u0107 vekovima \u2014 ali tek nedavno precizno dokumentovan. Kada fotoni odre\u0111ene talasne du\u017eine dopru do \u0107elije, mitohondrije ih apsorbuju kroz fotoreceptore \u2014 pre svega enzim citohrom c oksidazu (CCO), koji je \u010detvrta i klju\u010dna karika u mitohondrijalnom lancu transporta elektrona. Istra\u017eivanja objavljena na NIH PubMed platformi pokazuju da vi\u0161e od 50% apsorpcije svetlosti izme\u0111u 800 i 850 nm otpada upravo na citohrom c oksidazu. Rezultat ove apsorpcije je pove\u0107ana produkcija ATP-a \u2014 adenozin trifosfata, osnovne energetske valute svake \u0107elije. Vi\u0161e ATP-a zna\u010di bolje funkcionisanje metaboli\u010dkih procesa: br\u017ea popravka o\u0161te\u0107enih \u0107elija, ubrzana sinteza kolagena, regulisana upala, pobolj\u0161ana mikrocirkulacija. Ovaj kaskadni efekat dokumentovan je u hiljadama klini\u010dkih studija, sintetizovan u sistematskim pregledima u \u010dasopisima\u00a0Journal of Photochemistry and Photobiology,\u00a0Lasers in Surgery and Medicine, i\u00a0PMC (NIH).<\/p>\n<\/div><\/div>\n<\/div>\n<\/div><\/div>\n<\/div>\n\n\n\n

\n
\n
<\/div>
<\/div><\/div>
\n
\n

Le\u010denje svetlom<\/h3>\n\n\n\n

<\/h3>\n\n\n\n
Zaka\u017cite terapiju<\/span><\/svg><\/span><\/a><\/div>\n\n\n\n
\n
<\/div><\/div>
\n
465nm<\/h5>\n\n\n\n

Plava svetlost<\/strong><\/h4>\n\n\n\n

Deluje na povr\u0161ini ko\u017ee. Pobu\u0111uje endogene porfirin molekule unutar bakterije\u00a0Cutibacterium acnes, stvaraju\u0107i singletni kiseonik koji je baktericidan \u2014 bez antibiotika, bez rezistencije. Odabrana umesto 415 nm upravo zbog manjeg rizika od stimulacije melanogeneze.<\/p>\n<\/div><\/div><\/div>\n\n\n\n

<\/div><\/div>
\n
640nm<\/h5>\n\n\n\n

Crvena svetlost<\/strong><\/h4>\n\n\n\n

Prodire u dermis (do ~5\u201310 mm). Aktivira fibroblaste, stimuli\u0161e sintezu kolagena i elastina, smanjuje upalu i ubrzava zarastanje tkiva. Citohrom c oksidaza ima jedan od primarnih apsorpcionih pikova u crvenom spektru.<\/p>\n<\/div><\/div><\/div>\n\n\n\n

<\/div><\/div>
\n
880nm<\/h5>\n\n\n\n

Bliska infracrvena<\/strong><\/h4>\n\n\n\n

Dopire do subkutanog sloja, mi\u0161i\u0107a i zglobova. Smanjuje hroni\u010dnu upalu, pobolj\u0161ava cirkulaciju i umanjuje bol \u2014 mehanizmom koji uklju\u010duje modulaciju azot monoksida u mitohondrijalnom lancu i aktivaciju kalcijumskih jonskih kanala.<\/p>\n<\/div><\/div><\/div>\n<\/div><\/div><\/div>\n<\/div><\/div>\n<\/div><\/div><\/div>\n<\/div><\/div>\n<\/div><\/div>\n\n\n\n

<\/div>
<\/div><\/div>
\n
\n
\n
\n

Celluma koristi ove tri talasne du\u017eine sinergijski, ne naizmeni\u010dno. Svaki terapeutski program kontroli\u0161e kombinaciju talasnih du\u017eina, dozu (fluens u J\/cm\u00b2), pulsiranje i modulaciju svetlosnog talasa \u2014 u skladu sa klini\u010dkim protokolima specifi\u010dnim za svako stanje. Trideset minuta tretmana, u optimalnoj dozi i rastojanju, dovoljno je da se postigne terapeutski efekat dokumentovan u studijama.<\/p>\n<\/div><\/div>\n<\/div>\n<\/div><\/div><\/div>\n<\/div><\/div><\/section>\n\n\n\n

\n
\n
\n
\n

KO SME \/ NE SME DA KORISTI LED TERAPIJU?<\/h2>\n<\/div><\/div>\n<\/div>\n\n\n\n
\n
\n

INDIKACIJE<\/h3>\n\n\n\n
<\/div><\/div><\/span><\/div><\/div>\n\n\n\n

01. Akne vulgaris<\/strong><\/p>\n\n\n\n

Blaga do umerena akne. Plava svetlost uni\u0161tava\u00a0C. acnes\u00a0putem fototoksi\u010dnog efekta, crvena redukuje prate\u0107\u0443 upalu i ubrzava oporavak tkiva. Protokol: 3\u00d7 nedeljno, 4 nedelje.<\/p>\n\n\n\n

02. Starenje ko\u017ee<\/strong><\/p>\n\n\n\n

Fine linije i bore. Crvena i bliska infracrvena svetlost aktiviraju fibroblaste i podsti\u010du sintezu kolagena i elastina, pobolj\u0161avaju teksturu i ton ko\u017ee.<\/p>\n\n\n\n

03. Mi\u0161i\u0107ni i zglobni bol<\/strong><\/p>\n\n\n\n

Artralgija, mi\u0161i\u0107ni spazam, uko\u010denost. Bliska infracrvena svetlost penetrira do dubokih tkiva, smanjuje upalu i pobolj\u0161ava mikrocirkulaciju.<\/p>\n\n\n\n

04. Gubitak kose<\/strong><\/p>\n\n\n\n

Androgenetska alopecija (specifi\u010dne klasifikacije po Norwood-Hamilton i Ludwig-Savin skalama). Stimulacija folikula, pobolj\u0161anje zdravlja skalpa i pove\u0107anje gustine vlasi.<\/p>\n\n\n\n

05. Konturiranje tela<\/strong><\/p>\n\n\n\n

Redukcija lokalizovanog masnog tkiva. Svetlost aktivira privremene pore u membranama adipocita, \u0161to omogu\u0107ava isticanje lipida i njihov metabolizam.<\/p>\n\n\n\n

06.Zarastanje rana<\/strong><\/p>\n\n\n\n

Ubrzanje \u0107elijske regeneracije, smanjenje upale i podr\u0161ka oporavku tkiva \u2014 naro\u010dito u postproceduralnom kontekstu i kod hroni\u010dnih rana.<\/p>\n<\/div><\/div>\n\n\n\n

\n

KONTRAINDIKACIJE<\/h3>\n\n\n\n
<\/div><\/div><\/span><\/div><\/div>\n\n\n\n

01. Aktivna maligna bolest \/ metastaze<\/strong><\/p>\n\n\n\n

LED terapija se ne izvodi direktno iznad poznatog tumora ili metastatskog tkiva. Stimulacija \u0107elijske proliferacije koja je terapeutska u zdravom tkivu nije bezbedna u prisustvu malignih promena. Pacijenti koji su u remisiji konsultuju onkologa pre tretmana.<\/p>\n\n\n\n

02. Aktivna primena fotosenzitiziraju\u0107ih lekova<\/strong><\/p>\n\n\n\n

Lekovi koji pove\u0107avaju osetljivost tkiva na svetlost apsolutna su kontraindikacija dok su aktivni u organizmu. Period \u010dekanja zavisi od leka i njegove polueliminacije. Posebnu pa\u017enju zaslu\u017euje kategorija lekova koji sami po sebi pove\u0107avaju reaktivnost tkiva na svetlost. Kod ovih pacijenata tretman nije samo potencijalno neefikasan \u2014 mo\u017ee biti i kontraindikovana primena sve dok lek nije eliminisan iz organizma. <\/p>\n\n\n\n

Fotosenzitiziraju\u0107i lekovi \u2014 <\/strong>minimalni period \u010dekanja<\/p>\n\n\n\n

Izotretinoin (Roaccutane \/ Accutane) <\/strong>6 meseci od poslednje doze<\/p>\n\n\n\n

Tetraciklini (doksiciklin, minociklin)<\/strong>Tokom aktivne terapije \u2014 odlo\u017eiti<\/p>\n\n\n\n

Hlorpromazin (antipsihotik) <\/strong>8 dana od poslednje doze<\/p>\n\n\n\n

Grizeofulvin (antimikotik) <\/strong>5 dana od poslednje doze<\/p>\n\n\n\n

Kantarion (Hypericum perforatum) <\/strong>tokom aktivne primene \u2014 konsultovati lekara<\/p>\n\n\n\n

Odre\u0111eni NSAIL i diuretici<\/strong><\/p>\n\n\n\n

03. Deca<\/strong><\/p>\n\n\n\n

Celluma nije testirana u pedijatrijskoj populaciji i nije FDA-odobrena za primenu kod dece. Bezbednosni profil za razvojne faze tkiva nije utvr\u0111en klini\u010dkim studijama.<\/p>\n\n\n\n

04. Termalne kontraindikacije<\/strong><\/p>\n\n\n\n

Ure\u0111aj proizvodi blagi termi\u010dki efekat putem otpornika na \u0161tampanoj plo\u010di. Ukoliko je povi\u0161ena temperatura tkiva kontraindikovana (aktivna infekcija, upalno stanje u akutnoj fazi), tretman se odla\u017ee.<\/p>\n<\/div><\/div>\n\n\n\n

\n

RELATIVNE KONTRAINDIKACIJE UZ ODOBRENJE LEKARA<\/h3>\n\n\n\n
<\/div><\/div><\/span><\/div><\/div>\n\n\n\n

01. Trudno\u0107a i dojenje<\/strong><\/p>\n\n\n\n

Celluma se ne preporu\u010duje iznad abdomena tokom trudno\u0107e niti iznad grudi tokom dojenja. Tretman na drugim delovima tela mogu\u0107 je uz pismenu saglasnost ginekologa. Klini\u010dki podaci o primeni u trudno\u0107i su ograni\u010deni.<\/p>\n\n\n\n

02. Epilepsija \/ konvulzivni poreme\u0107aji<\/strong><\/p>\n\n\n\n

Pulsiraju\u0107a svetlost mo\u017ee kod osjetljivih osoba predstavljati okida\u010d. Tretman je mogu\u0107 uz pisanu saglasnost neurologa koji prati pacijenta.<\/p>\n\n\n\n

03. Fotosenzitivni dermatolo\u0161ki poreme\u0107aji<\/strong><\/p>\n\n\n\n

Lupus eritematodes, porfiria, polimorfna svetlosna erupcija i sli\u010dni poreme\u0107aji zahtevaju procenu dermatologa pre uklju\u010divanja u protokol. Pove\u0107ana reaktivnost na svetlost varira po te\u017eini i tipu poreme\u0107aja.<\/p>\n\n\n\n

04. Steroidi \u2014 sistemski i lokalni<\/strong><\/p>\n\n\n\n

Kod sistemske primene steroida konsultuje se lekar. Nakon steroidnih injekcija preporu\u010duje se pauza od najmanje 7 dana pre tretmana, osim uz eksplicitno odobrenje lekara.<\/p>\n\n\n\n

05.Aktivne ko\u017ene infekcije u zoni tretmana<\/strong><\/p>\n\n\n\n

Akutni herpes simplex, otvorene rane infektivnog porekla i celulitis u akutnoj fazi relativne su kontraindikacije. Termi\u010dki efekat mo\u017ee pogor\u0161ati stanje ili pro\u0161iriti infekciju. Hroni\u010dne rane i postproceduralni oporavak su indikacija, a ne kontraindikacija.<\/p>\n<\/div><\/div>\n<\/div>\n<\/div><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":295,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_nectar_blocks_hide_post_title":true,"_nectar_blocks_transparent_header_effect":true,"_nectar_blocks_transparent_header_effect_color":"light","_nectar_blocks_header_animation":true,"_nectar_blocks_header_animation_delay":0,"_nectar_blocks_header_animation_effect":"fade","_nectar_blocks_page_css":"","_nectar_blocks_page_js":"","footnotes":""},"categories":[37],"tags":[],"class_list":["post-1685","page","type-page","status-publish","has-post-thumbnail","category-materijali"],"yoast_head":"\nCELLUMA - Sovea<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/sovea.rs\/?page_id=1685\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CELLUMA - Sovea\" \/>\n<meta property=\"og:url\" content=\"https:\/\/sovea.rs\/?page_id=1685\" \/>\n<meta property=\"og:site_name\" content=\"Sovea\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-23T18:17:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/sovea.rs\/wp-content\/uploads\/2025\/03\/crimson-echo.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"2200\" \/>\n\t<meta property=\"og:image:height\" content=\"1467\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/sovea.rs\\\/?page_id=1685\",\"url\":\"https:\\\/\\\/sovea.rs\\\/?page_id=1685\",\"name\":\"CELLUMA - Sovea\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/sovea.rs\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/sovea.rs\\\/?page_id=1685#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/sovea.rs\\\/?page_id=1685#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/sovea.rs\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/crimson-echo.webp\",\"datePublished\":\"2026-04-19T09:05:13+00:00\",\"dateModified\":\"2026-04-23T18:17:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/sovea.rs\\\/?page_id=1685#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/sovea.rs\\\/?page_id=1685\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/sovea.rs\\\/?page_id=1685#primaryimage\",\"url\":\"https:\\\/\\\/sovea.rs\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/crimson-echo.webp\",\"contentUrl\":\"https:\\\/\\\/sovea.rs\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/crimson-echo.webp\",\"width\":2200,\"height\":1467},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/sovea.rs\\\/?page_id=1685#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/sovea.rs\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CELLUMA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/sovea.rs\\\/#website\",\"url\":\"https:\\\/\\\/sovea.rs\\\/\",\"name\":\"Sovea\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/sovea.rs\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CELLUMA - Sovea","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/sovea.rs\/?page_id=1685","og_locale":"en_US","og_type":"article","og_title":"CELLUMA - Sovea","og_url":"https:\/\/sovea.rs\/?page_id=1685","og_site_name":"Sovea","article_modified_time":"2026-04-23T18:17:52+00:00","og_image":[{"width":2200,"height":1467,"url":"https:\/\/sovea.rs\/wp-content\/uploads\/2025\/03\/crimson-echo.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/sovea.rs\/?page_id=1685","url":"https:\/\/sovea.rs\/?page_id=1685","name":"CELLUMA - Sovea","isPartOf":{"@id":"https:\/\/sovea.rs\/#website"},"primaryImageOfPage":{"@id":"https:\/\/sovea.rs\/?page_id=1685#primaryimage"},"image":{"@id":"https:\/\/sovea.rs\/?page_id=1685#primaryimage"},"thumbnailUrl":"https:\/\/sovea.rs\/wp-content\/uploads\/2025\/03\/crimson-echo.webp","datePublished":"2026-04-19T09:05:13+00:00","dateModified":"2026-04-23T18:17:52+00:00","breadcrumb":{"@id":"https:\/\/sovea.rs\/?page_id=1685#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/sovea.rs\/?page_id=1685"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/sovea.rs\/?page_id=1685#primaryimage","url":"https:\/\/sovea.rs\/wp-content\/uploads\/2025\/03\/crimson-echo.webp","contentUrl":"https:\/\/sovea.rs\/wp-content\/uploads\/2025\/03\/crimson-echo.webp","width":2200,"height":1467},{"@type":"BreadcrumbList","@id":"https:\/\/sovea.rs\/?page_id=1685#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/sovea.rs\/"},{"@type":"ListItem","position":2,"name":"CELLUMA"}]},{"@type":"WebSite","@id":"https:\/\/sovea.rs\/#website","url":"https:\/\/sovea.rs\/","name":"Sovea","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/sovea.rs\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/sovea.rs\/index.php?rest_route=\/wp\/v2\/pages\/1685","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sovea.rs\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/sovea.rs\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/sovea.rs\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/sovea.rs\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1685"}],"version-history":[{"count":44,"href":"https:\/\/sovea.rs\/index.php?rest_route=\/wp\/v2\/pages\/1685\/revisions"}],"predecessor-version":[{"id":2571,"href":"https:\/\/sovea.rs\/index.php?rest_route=\/wp\/v2\/pages\/1685\/revisions\/2571"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sovea.rs\/index.php?rest_route=\/wp\/v2\/media\/295"}],"wp:attachment":[{"href":"https:\/\/sovea.rs\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1685"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sovea.rs\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1685"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sovea.rs\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1685"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}